たしかにプラス Company Profile

This is a notice from the "Japan Food Evidence Association," where our representative also serves as the representative director. On September 29, 2023, the Consumer Affairs Agency revised the guidelines for functional labeling foods. To promptly inform businesses about the key points of the revision and the latest notification trends, the Japan Food Evidence Association has produced explanatory videos. Those who wish to become supporting members of our association (corporate or individual members) can view some of the videos for free (limited time). Our association will continue to provide useful videos and information for businesses as needed. We encourage businesses interested in viewing all videos and seeking support for functional labeling food notifications to consider joining at this opportunity. We will decline membership registration and video viewing requests from those we determine to be competitors or similar entities. You can view the materials from the "Notice of Video Distribution" PDF in the related materials below. To apply, click here: https://food-evidence.jp/developer/doui/ Japan Food Evidence Association Secretariat Email: info@food-evidence.jp

"Indeed Plus" has built a track record of 10 years as a company providing support to medical institutions. We primarily respond to a wide range of tests related to safety and efficacy in the field of clinical trials, conducting tests such as overdose trials, long-term safety trials, cognitive function, triglycerides, and blood sugar levels. We offer comprehensive support from product development to the preparation of application documents, research reviews, and communication with the Consumer Affairs Agency. Our strength lies particularly in our total support for the entire process from recruiting test subjects to obtaining informed consent, collecting case reports, statistical analysis, and reporting results. Furthermore, ethical reviews are conducted by medical professionals, ensuring high quality. The key to success in clinical trials is to minimize the number of people involved in development. Additionally, by formulating protocols specialized in the development of functional foods, we achieve high success rates at low costs. (Article Summary)

Our company "Tashika ni Plus" was featured in the October 4, 2023 issue (No. 1773) of the Health Industry Newspaper. The article focuses on the services of EFMA (Evidence Food Market), emphasizing its role as an e-commerce site that selectively offers health functional foods based on evidence. By clarifying the differences between functional labeled foods and general health foods, it introduces efforts to enhance brand value. Key features of EFMA include: 1. A strategy to attract the interest of younger consumers through detailed information provision and the creation of highly reliable landing pages. 2. Compliance with regulations to provide an environment where consumers can purchase with confidence. 3. A system that allows for the purchase of all products and one-stop listing, with a listing fee set at 50,000 yen. Furthermore, the EFMA site features 11 products and continues to support the notification of functional labeled foods. Through these initiatives, our company "Tashika ni Plus" aims to provide consumers with truthful information and enhance the reliability of the health food market!